Skip to main content
. 2023 Mar 3;28(5):2356. doi: 10.3390/molecules28052356

Table 3.

Evaluation of the inhibitory activity of 3a and 3ae against SARS-CoV-2 Proteases.

Compound Structure SARS-CoV-2 Mpro SARS-CoV-2 PLpro
3a graphic file with name molecules-28-02356-i002.jpg 23.39% n.i.
3ea graphic file with name molecules-28-02356-i003.jpg 23.70% n.i.
Nirmaltrevir graphic file with name molecules-28-02356-i004.jpg 0.003 ± 0.0004 μM a -

Notes: % of inhibition of the enzymatic activity at 20 μM; a IC50 was determined for Nirmaltrevir; IC50 value includes standard deviation from two independent experiments, each performed in triplicate; n.i. = no inhibition.